Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Our Featured Weight-Loss Products Compounded Tirzepatide Injections Dual-action GLP-1 and GIP receptor agonist Starting at $349/month Benefits may include: Up to 10% weight loss* Slowed digestion Reduced appetite Blood sugar regulation Easy use Compounded Semaglutide Injections GLP-1 receptor agonist Starting at $249/month Benefits may include: Up to 10% weight loss* Slowed digestion Reduced appetite Blood sugar regulation Easy use Wegovy GLP-1 receptor agonist FDA-approved for chronic weight management Starting at $349/month Benefits may include: Up to 20% weight loss** Slowed digestion Reduced cravings Healthy metabolic function Clinically-proven treatment Zepbound Dual-action GLP-1 receptor agonist FDA-approved for chronic weight management Starting at $349/month Benefits may include: Slowed digestion Regulated blood sugar More controlled appetite Managed blood sugar GLP-1 Liquid Drops Oral semaglutide GLP-1 Starting at $229/month Benefits may include: Needle-free support Feeling full longer Slowed digestion Healthy blood sugar levels GLP-1 Lozenges Oral GLP-1 Starting at $199/month Benefits may include: Needle-free support Feeling full longer Slowed digestion Healthy blood sugar levels Mouth-dissolving formula MIC + B12 Energy and metabolism support Starting at $115/month Benefits may include: Regulated appetite Metabolic support Enhanced focus and clarity Energy support Naltrexone + Bupropion Support for balanced eating habits Starting at $115/month Benefits may include: Reduced cravings Reduced food noise Improved mood Gentle weight-loss support Metformin + Naltrexone + Topiramate Triple medication capsule to support your wellness goals Starting at $169/month Benefits may include: Needle-free support Metabolic health support Healthy appetite cues Improved insulin sensitivity **In clinical trials of Wegovy, average weight loss was about 15% overall, with up to ~20% seen in longer-term or higher-adherence trial groups, when paired with diet and exercise (compared to 2.4% and 3.1% with diet and exercise alone)
GLP-1 drugs are currently FDA-approved for diabetes management, weight loss and reducing cardiovascular risk
Approvals for cardiovascular risk reduction and ongoing trials in Alzheimer's disease, sleep apnea, and depression are dramatically widening the addressable population
A 2017 trial using 250 milligrams a day showed some improvement along with melanin reduction, though glutathione works better as antioxidant support than as a standalone wrinkle treatment
Clinical Update 11/04/2024 Can you get too much protein
Advance Targeted Endocrine Research With Selective GH Secretagogue Peptides Researchers frequently encounter challenges when evaluating endocrine signaling pathways, including limited receptor specificity, inconsistent peptide characterization, and variability in hormonal assay results
